4BCI

Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor

4BCI の概要

• エントリーDOI: 10.2210/pdb4bci/pdb
• 関連するPDBエントリー: 1PF6 4BCF 4BCG 4BCH 4BCJ 4BCK 4BCM 4BCN 4BCO 4BCP 4BCQ
• 分子名称: CYCLIN-DEPENDENT KINASE 9, CYCLIN-T1, 3-[[5-cyano-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide, ... (4 entities in total)
• 機能のキーワード: transferase-cell cycle complex, cdk-cyclin complex, transcription-protein binding, structure-based drug design, transferase/cell cycle
• 由来する生物種: HOMO SAPIENS (HUMAN); 詳細
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 68574.97

構造登録者

Hole, A.J.,Baumli, S.,Wang, S.,Endicott, J.A.,Noble, M.E.M. (登録日: 2012-10-02, 公開日: 2013-01-09, 最終更新日: 2019-05-15)

• 主引用文献: Hole, A.J.,Baumli, S.,Shao, H.,Shi, S.,Pepper, C.,Fischer, P.M.,Wang, S.,Endicott, J.A.,Noble, M.E.M.; Comparative Structural and Functional Studies of 4-(Thiazol- 5-Yl)-2-(Phenylamino)Pyrimidine-5-Carbonitrile Cdk9 Inhibitors Suggest the Basis for Isotype Selectivity.; J.Med.Chem., 56:660-, 2013; PubMed: 23252711; DOI: 10.1021/JM301495V

実験手法

X-RAY DIFFRACTION (3.1 Å)